News + Filings Holdings
|
BioImpact Capital LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
Cullinan Oncology, Inc.
| CGEM | Common | 7,648,268 | 0 | 82,295,364,000 | 4,053,582,000 | 16.57 | 19.43 |
Hist
| 06/30/2023 |
IVERIC bio, Inc.
| ISEE | COM | 1,214,662 | 168,971 | 47,784,803,000 | 22,343,141,000 | 9.62 | 0.88 |
Hist
| 06/30/2023 |
CHINOOK THERAPEUTICS, INC.
| KDNY | Common | 1,003,406 | 805,600 | 38,550,859,000 | 33,971,650,000 | 7.76 | 1.50 |
Hist
| 06/30/2023 |
GERON CORP
| GERN | COM | 9,191,290 | 789,725 | 29,504,041,000 | 11,272,645,000 | 5.94 | 1.81 |
Hist
| 06/30/2023 |
REATA PHARMACEUTICALS INC
| RETA | Common | 234,478 | 57,604 | 23,907,377,000 | 7,362,583,000 | 4.81 | 0.62 |
Hist
| 06/30/2023 |
iTeos Therapeutics, Inc.
| ITOS | Common | 1,745,943 | 0 | 23,116,285,000 | -645,999,000 | 4.65 | 4.88 |
Hist
| 06/30/2023 |
Intellia Therapeutics, Inc.
| NTLA | Common | 544,639 | -27,820 | 22,210,378,000 | 874,831,000 | 4.47 | 0.62 |
Hist
| 06/30/2023 |
IOVANCE BIOTHERAPEUTICS, INC.
| IOVA | COM | 2,950,118 | 335,141 | 20,768,831,000 | 4,791,322,000 | 4.18 | 1.31 |
Hist
| 06/30/2023 |
Repare Therapeutics Inc.
| RPTX | Common | 1,639,849 | 0 | 17,349,602,000 | 1,213,488,000 | 3.49 | 3.90 |
Hist
| 06/30/2023 |
Relay Therapeutics, Inc.
| RLAY | Stock | 1,354,368 | 128,734 | 17,010,862,000 | -3,175,330,000 | 3.43 | 1.11 |
Hist
| 06/30/2023 |
Verve Therapeutics, Inc.
| VERV | Common | 857,940 | 54,439 | 16,086,375,000 | 4,499,891,000 | 3.24 | 1.39 |
Hist
| 06/30/2023 |
MoonLake Immunotherapeutics
| MLTX | Common | 295,111 | 295,111 | 15,050,661,000 | 15,050,661,000 | 3.03 | 0.56 |
Hist
| 06/30/2023 |
REGENXBIO Inc.
| RGNX | COM | 656,718 | 39,047 | 13,127,793,000 | 1,447,634,000 | 2.64 | 1.51 |
Hist
| 06/30/2023 |
Karuna Therapeutics, Inc.
| KRTX | Common | 53,399 | 53,399 | 11,579,573,000 | 11,579,573,000 | 2.33 | 0.15 |
Hist
| 06/30/2023 |
INSMED Inc
| INSM | Common | 529,743 | 130,551 | 11,177,577,000 | 4,371,353,000 | 2.25 | 0.39 |
Hist
| 06/30/2023 |
Xeris Biopharma Holdings, Inc.
| XERS | COM | 3,974,999 | 3,974,999 | 10,414,497,000 | 10,414,497,000 | 2.10 | 2.89 |
Hist
| 06/30/2023 |
MADRIGAL PHARMACEUTICALS, INC.
| MDGL | Common | 38,011 | 1,973 | 8,780,541,000 | 49,975,000 | 1.77 | 0.21 |
Hist
| 06/30/2023 |
Crinetics Pharmaceuticals, Inc.
| CRNX | Common | 479,053 | 118,661 | 8,632,535,000 | 2,844,639,000 | 1.74 | 0.89 |
Hist
| 06/30/2023 |
Travere Therapeutics, Inc.
| TVTX | Common | 552,846 | 239,204 | 8,491,715,000 | 1,437,906,000 | 1.71 | 0.85 |
Hist
| 06/30/2023 |
Revolution Medicines, Inc.
| RVMD | Common | 273,408 | 26,386 | 7,313,664,000 | 1,963,167,000 | 1.47 | 0.26 |
Hist
| 06/30/2023 |
Werewolf Therapeutics, Inc.
| HOWL | Common | 2,388,011 | 0 | 7,283,434,000 | 1,074,605,000 | 1.47 | 6.71 |
Hist
| 06/30/2023 |
KalVista Pharmaceuticals, Inc.
| KALV | Common | 761,538 | 761,538 | 6,853,842,000 | 6,853,842,000 | 1.38 | 2.22 |
Hist
| 06/30/2023 |
Axsome Therapeutics, Inc.
| AXSM | COM | 93,586 | 23,184 | 6,725,090,000 | 2,382,695,000 | 1.35 | |
Hist
| 06/30/2023 |
AMICUS THERAPEUTICS, INC.
| FOLD | COM | 516,139 | 127,847 | 6,482,706,000 | 2,176,548,000 | 1.31 | 0.18 |
Hist
| 06/30/2023 |
AVADEL PHARMACEUTICALS PLC
| AVDL | SPONSORED ADR | 384,990 | 384,990 | 6,344,635,000 | 6,344,635,000 | 1.28 | |
Hist
| 06/30/2023 |
Viridian Therapeutics, Inc.\DE
| VRDN | COM | 255,323 | 255,323 | 6,074,134,000 | 6,074,134,000 | 1.22 | 0.59 |
Hist
| 06/30/2023 |
Edgewise Therapeutics, Inc.
| EWTX | Common | 712,798 | 712,798 | 5,524,185,000 | 5,524,185,000 | 1.11 | 1.13 |
Hist
| 06/30/2023 |
Adaptimmune Therapeutics PLC
| ADAP | Common | 5,095,912 | 5,095,912 | 4,713,719,000 | 4,713,719,000 | 0.95 | 0.51 |
Hist
| 06/30/2023 |
Olema Pharmaceuticals, Inc.
| OLMA | Common | 462,500 | 462,500 | 4,176,375,000 | 4,176,375,000 | 0.84 | 1.13 |
Hist
| 06/30/2023 |
Phathom Pharmaceuticals, Inc.
| PHAT | Common | 282,332 | 69,717 | 4,042,994,000 | 2,524,923,000 | 0.81 | 0.65 |
Hist
| 06/30/2023 |
Harpoon Therapeutics, Inc.
| HARP | Common | 3,196,707 | 0 | 2,269,662,000 | -108,688,000 | 0.46 | 8.50 |
Hist
| 06/30/2023 |
Inozyme Pharma, Inc.
| INZY | Common | 326,921 | 93,193 | 1,820,950,000 | 481,689,000 | 0.37 | 0.74 |
Hist
| 06/30/2023 |
Ventyx Biosciences, Inc.
| VTYX | Common | 31,747 | 31,747 | 1,041,302,000 | 1,041,302,000 | 0.21 | 0.05 |
Hist
| 06/30/2023 |
Oncorus, Inc.
| ONCR | Common | 2,377,031 | 0 | 96,270,000 | -721,429,000 | 0.02 | 9.11 |
Hist
| 06/30/2023 |
TCR2 THERAPEUTICS INC.
| TCRR | Common | 0 | -3,370,982 | 0 | -5,056,473,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
<< Prev Next >> |
|
|
|
|